BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 30, 2020
View Archived Issues
"Don't Eat Me" signal doubles as "Don't Find Me"
Read More
Oral tebipenem demonstrates noninferiority to i.v. ertapenem in cUTI and AP
Read More
First patient enrolled in phase I study of AIC-100 CAR T cells for thyroid cancer
Read More
Aveni Foundation initiates phase I/II study of DeltaRex-G for COVID-19
Read More
Phase III study of 18F-APN-1607 tau PET tracer approved in China
Read More
Novartis and Molecular Partners collaborate to develop two DARPin therapies against COVID-19
Read More
Six months of therapy completed in low-dose cohort of phase I/II brain cancer study of NOX-A12
Read More
Lynk Pharmaceuticals discloses new JAK inhibitors
Read More
Zhuhai Yufan Biotechnologies patents CDK inhibitors
Read More
Qilu Regor Therapeutics identifies tyrosine kinase inhibitors
Read More
Accutar Biotechnology synthesizes new PROTACs for cancer
Read More
University of Massachusetts presents factor H vectors
Read More
First patient dosed in dose-expansion evaluating DSP-7888 plus pembrolizumab in ovarian cancer
Read More
MEDI-3902 may reduce incidence of P. aeruginosa pneumonia in specific populations
Read More
Initiation of phase I/II GOBLET study of pelareorep plus atezolizumab in GI cancers
Read More
Daewoong's sustained-release niclosamide shows efficacy against both COVID-19 and seasonal flu
Read More
Xoma earns milestone payment from Novartis as NIS-793 enters phase II development
Read More
Astellas Pharma's pneumococcal vaccine demonstrates highly immunogenic properties
Read More
"Foundational" research shows early gene therapy prevents Angelman syndrome
Read More
MediWound completes enrollment in phase II pediatric study of NexoBrid
Read More
First results from IPAX-1 clinical trial for GBM
Read More
FDA gives positive pre-IND response for clinical development of AS-1411 for COVID-19
Read More
CStone, LegoChem enter global licensing agreement for new antibody-drug conjugate
Read More
PeproMene submits IND for PMB-101 for the treatment of B-ALL
Read More
Insignis, HLK Pharmacin receive FDA IND clearance for phase I trial of IN-001 in anaphylaxis
Read More
Topline results from phase II AURORA trial of avacopan reported
Read More